| 000 | 01803 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514065906.0 | ||
| 264 | 0 | _c20030625 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/375194 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRazonable, Raymund R | |
| 245 | 0 | 0 |
_aDynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cJun 2003 |
||
| 300 |
_a1801-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCytomegalovirus _xdrug effects |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xprevention & control |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanciclovir _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLiver _xsurgery |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOpportunistic Infections _xprevention & control |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 |
_aViremia _xprevention & control |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _avan Cruijsen, Hester | |
| 700 | 1 | _aBrown, Robert A | |
| 700 | 1 | _aWilson, Jennie A | |
| 700 | 1 | _aHarmsen, William S | |
| 700 | 1 | _aWiesner, Russell H | |
| 700 | 1 | _aSmith, Thomas F | |
| 700 | 1 | _aPaya, Carlos V | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 187 _gno. 11 _gp. 1801-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/375194 _zAvailable from publisher's website |
| 999 |
_c12539310 _d12539310 |
||